플럼라인생명과학

Anthony Kim

President & CEO
- VGX Pharma Senior Director(Current Inovio)
- VGX International, MD
- Wells Fargo Bank Br. Mgr.
- Bank of America Br. Mgr.
- Equity Analyst/Trading, International Division, SK Securities
Sang Joon Lee, Ph.D.

Independent
- President, Korea Institute of Toxicology
- VP, Kolon Life Science
- Head of Technical department, ChongKunDang
- M.S. at Chung-Ang Univ.
Joo Hyun Kim, Esq

Director
- Attorney, Law Serve
- Yeungnam University, Graduate School of Law
- Yonsei University, Graduate School of Law
- Yonsei University, Law School
Jung Il Kim, CPA

Auditor
- Seyeon accounting corporation
- Anjin accounting corporation

Anthony Kim

President & CEO
- VGX Pharma Senior Director(Current Inovio)
- VGX International, MD
- Wells Fargo Bank Br. Mgr.
- Bank of America Br. Mgr.
- Equity Analyst/Trading, International Division, SK Securities
Sang Joon Lee, Ph.D.

Independent
- President, Korea Institute of Toxicology
- VP, Kolon Life Science
- Head of Technical department, ChongKunDang
- M.S. at Chung-Ang Univ.
Joo Hyun Kim, Esq

Independent
- Attorney, Law Serve
- Yeungnam University, Graduate School of Law
- Yonsei University, Graduate School of Law
- Yonsei University, Law School
Jung Il Kim, CPA

Auditor
- Seyeon accounting corporation
- Anjin accounting corporation
Eun Jin Kim, Ph.D.

CSDO
- Abion R&D Institute Adviser
- Seoul National University Biological Sciences, Researcher
- Yonsei Univ. Med. School Research Assistant Professor
- Ph.D. Texas A&M University
- M.S. Texas A&M University

Anthony Kim